Integrative Medicine of IgA Nephropathy
Treatment of Shentong Granules Plus Prednisone on Patients With Severe IgA Nephropathy(Ying-deficiency of the Liver and Kidney Pattern): a Randomized, Double-blind,Placebo-controlled Multicentre Clinical Trial
Sponsor: Fudan University
A NA clinical study on Primary IgA Nephropathy, this trial is ongoing. The trial is conducted by Fudan University and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
-
Feb 2018 — Jun 2018 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
▶ Show 1 earlier version
-
Jan 2017 — Feb 2018 [monthly]
Not Yet Recruiting NA
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fudan University
- RenJi Hospital
- Ruijin Hospital
- Shanghai 6th People's Hospital
- Shanghai University of Traditional Chinese Medicine
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .